LT-5

General Information


DRACP ID  DRACP06080

Peptide Name   LT-5

Sequence  LRQAPGQNGTSFHGCIRNLYINSE

Sequence Length  24

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic (Derived from SLIT2 protein)

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C114H179N37O36S

Absent amino acids  DKMVW

Common amino acids  GN

Mass  308639

Pl  8.53

Basic residues  3

Acidic residues  1

Hydrophobic residues  6

Net charge  2

Boman Index  -5325

Hydrophobicity  -66.25

Aliphatic Index  69.17

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  1490

Absorbance 280nm  64.78

Polar residues  11

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID CN111032679A

Patent Title  Peptides for Cancer Treatment

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.